Stifel Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St subdued in choppy trade after big bank earnings, chips slide
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| (NASDAQ: DNLI) | Delayed: 18.37 -0.58 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.95 | 52 Week High | $ | |||
| Open | $18.82 | 52 Week Low | $ | |||
| Day High | $19.20 | P/E | N/A | |||
| Day Low | $18.33 | EPS | $ | |||
| Volume | 343,626 | |||||
